Publication|Articles|February 18, 2026
- Pharmaceutical Executive: February 2026
- Volume 46
- Issue 1
Pharmaceutical Executive: February 2026 Interactive Digital Edition
View the Pharmaceutical Executive February 2026 issue in an interactive format.
Advertisement
Click
Articles in this issue
about 2 months ago
A New Pharma Playbookabout 2 months ago
Leonard Mazur: The Adventures of a Serial Entrepreneurabout 2 months ago
When Friction Meets Force in Clinical Researchabout 2 months ago
Pharm Exec's 2026 Pipeline Report: Next Frontiers in Focusabout 2 months ago
Today’s China Crucible: What It Means for Pharma2 months ago
Taking Advantage of ‘Hidden Gem’ Talent Hubs2 months ago
To Build or to Buy: Determining Your AI PathNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Foundayo Under National Priority Voucher Program
2
Biogen Enters $5.6 Billion Agreement to Acquire Apellis Pharmaceuticals
3
Pharmaceutical Executive Daily: Trump Administration Delays Appeal of Federal Ruling Blocking Vaccine Policy Overhaul
4
Being Specific About Being General: Vaccines Edition
5
